SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008540
Filing Date
2023-05-08
Accepted
2023-05-08 16:30:53
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 2391813
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 9641
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 9604
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 5711
5 EX-32.2 tmb-20230331xex32d2.htm EX-32.2 5698
  Complete submission text file 0001558370-23-008540.txt   11726108

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230331.xsd EX-101.SCH 51102
7 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 84726
8 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 227730
9 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 467518
10 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 424228
74 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 3087617
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17272 | Film No.: 23898228
SIC: 2836 Biological Products, (No Diagnostic Substances)